| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.2 |